K. Nomoto

Active 1978–2023

Also published as
K Nomoto
105
Papers
30,367
Citations
84
h-index
105
i10-index

Citations

Citations per year for K. Nomoto1978: 4 citations1979: 1 citations1984: 2 citations1987: 2 citations1988: 5 citations1989: 2 citations1990: 6 citations1991: 6 citations1992: 17 citations1993: 31 citations1994: 10 citations1995: 29 citations1996: 32 citations1997: 54 citations1998: 58 citations1999: 78 citations2000: 66 citations2001: 68 citations2002: 97 citations2003: 116 citations2004: 118 citations2005: 96 citations2006: 217 citations2007: 192 citations2008: 119 citations2009: 121 citations2010: 118 citations2011: 142 citations2012: 128 citations2013: 126 citations2014: 119 citations2015: 88 citations2016: 71 citations2017: 92 citations2018: 69 citations2019: 171 citations2020: 236 citations2021: 260 citations2022: 166 citations2023: 152 citations2024: 219 citations2025: 81 citations2026: 1 citations1980–1983: no citations, so these years are not shown1985–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,145 citing papers, 23.2% of this breakdownJapan: 449 citing papers, 9.1% of this breakdownChina: 430 citing papers, 8.7% of this breakdownGermany: 373 citing papers, 7.6% of this breakdownUnited Kingdom: 319 citing papers, 6.5% of this breakdownItaly: 262 citing papers, 5.3% of this breakdownFrance: 197 citing papers, 4% of this breakdownAustralia: 177 citing papers, 3.6% of this breakdownSpain: 151 citing papers, 3.1% of this breakdownCanada: 120 citing papers, 2.4% of this breakdownNetherlands: 118 citing papers, 2.4% of this breakdownSouth Korea: 82 citing papers, 1.7% of this breakdown
0%23.2%Other 22.4%

Fields

  • Medicine35.8%
  • Physics and Astronomy30.6%
  • Biochemistry, Genetics and Molecular Biology15%
  • Immunology and Microbiology9.9%
  • Agricultural and Biological Sciences2.4%
  • Nursing2%
  • Other4.3%

Topics

  • Gamma-ray bursts and supernovae7.8%
  • Stellar, planetary, and galactic studies4.2%
  • Pulsars and Gravitational Waves Research3.3%
  • Cancer Immunotherapy and Biomarkers3.2%
  • Hepatocellular Carcinoma Treatment and Prognosis3.1%
  • Immune Cell Function and Interaction2.6%
  • Other75.8%

Coauthors

All papers

Open in search
  1. Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway

    Authors: , , , , , , , , , , , , , , , - PLoS ONE 2019 cited by 463

  2. Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

    Authors: , , , , , , , , , , , , - Cancer Science 2018 cited by 342

  3. Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Vascular Cell 2014 cited by 500

  4. Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models

    Authors: , , , , , , , , , , , , , , , , , - Cancer Science 2014 cited by 278

  5. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takashi Owa, Yasuhiro Funahashi, Yoichi Ozawa - Cancer Research 2021 cited by 61

  6. EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity

    Authors: , , , , , , , , , , , , , , , , , - OncoImmunology 2017 cited by 94

  7. E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling

    Authors: , , , , , , , , , , , - Oncotarget 2015 cited by 87

  8. Distribution of coronal plane alignment of the knee classification does not change as knee osteoarthritis progresses: a longitudinal study from the Toei study

    Authors: , , , - Knee Surgery Sports Traumatology Arthroscopy 2023 cited by 31

  9. Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR–MAPK cascades

    Authors: , , , , , , , , - Biochemical and Biophysical Research Communications 2019 cited by 77

  10. Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61

    Authors: , , , , , , , , , , , , , , , , , , - Molecular Cancer Therapeutics 2016 cited by 75

  11. Nucleosynthesis in Stars and the Chemical Enrichment of Galaxies

    Authors: , , - Annual Review of Astronomy and Astrophysics 2013 cited by 1,072

  12. Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome: a preliminary study

    Authors: , , , , , , , , , , , , - Neurogastroenterology & Motility 2010 cited by 95

  13. High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study

    Authors: , , , , , , , , , , , - Breast Cancer 2020 cited by 79

  14. High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cancer Research 2021 cited by 33

  15. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent

    Authors: , , , , , , , , , , , , - Gut 2007 cited by 224

  16. Molecular monitoring of the development of intestinal microbiota in Japanese infants

    Authors: , , , , , , , , , , - Beneficial Microbes 2012 cited by 84

  17. Increased susceptibility to primary infection with Listeria monocytogenes in germfree mice may be due to lack of accumulation of L-selectin+ CD44+ T cells in sites of inflammation

    Authors: , , , - Infection and Immunity 1996 cited by 76

  18. Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma

    Authors: , , , , , , , - Cancer Investigation 2019 cited by 21

  19. An unusual supernova in the error box of the γ-ray burst of 25 April 1998

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. A. M. J. Wijers, N. R. Tanvir, J. Greiner, E. Pian, E. Palazzi, F. Frontera, N. Masetti, L. Nicastro, M. Feroci, E. Costa, L. Piro, B. A. Peterson, C. G. Tinney, B. Boyle, Russell Cannon, R. A. Stathakis, E. M. Sadler, M. C. Begam, P. A. Ianna - Nature 1998 cited by 1,940

  20. A lithium superionic conductor for millimeter-thick battery electrode

    Authors: , , , , , , , , , , , , , - Science 2023 cited by 477

  21. The First Chemical Enrichment in the Universe and the Formation of Hyper Metal-Poor Stars

    Authors: , , , , - Science 2005 cited by 266

  22. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides

    Authors: , , , , - Journal of Applied Microbiology 2001 cited by 144

  23. Effect of dietary anti‐Helicobacter pylori‐urease immunoglobulin Y on Helicobacter pylori infection

    Authors: , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2004 cited by 80

  24. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.

    Authors: , , , , , - The Journal of Immunology 1990 cited by 80